The effect of phenotype switching on ILEI expression. by Ken Noguchi (255943)

Effect of NAT1 knockout on cell growth in normal and low glucose. by LiLi Wang (1582915)

Bile acid composition is altered in SKO mice. by Sabrina N. Dumas (5474456)

Study timeline and methodological overview. by Robert Botelho (20308297)

Percentage final biomass changes over 30 years (a) for scenarios 2 and 3 relative to scenario 1 (i.e. low fishing scenarios) (b) for scenarios 5 and 6 relative to scenario 4 (i.e. high fishing scenarios). for the nine functional groups that showed a decrease/increase of more than 8% in at least one of the scenarios. by Marie Savina (402195)

Direct monetary reward in the PRT using a control population led to a reward induced bias. by Matthew Paul Wilkinson (11824625)

Unraveling the impact of ORF3a Q57H mutation on SARS-CoV-2: insights from molecular dynamics by Md. Jahirul Islam (2567767)

“…<p>ORF3a is a conserved accessory protein of SARS-CoV-2, linked to viral infection and pathogenesis, with acquired mutations at various locations. …”

Fig 2 - by Oliver Campbell (17283127)

Schematic representation of tumor kinetics study in diabetic and non-diabetic mice. by Vidya G. Bettada (22208808)

Comparative death probabilities of tumor-bearing mice across weeks of assessment. by Robert Botelho (20308297)

PEA performed for different durations of incubation after the dilution step, for three concentrations of rPCT. by Frederic Bedin (3402254)

“…<p>The incubation time after dilution of the binding product was progressively decreased from 5 min (reference test, ref.) down to 30 sec. …”

Data used in analysis. by Rong Tang (130779)

“…This study aimed to compare the analgesic efficacies of different adjuvants with 0.375% ropivacaine in ultrasound-guided TPVB for VATS.</p><p>Methods</p><p>A total of 120 patients who underwent VATS at the study hospital in 2022–2023 were recruited and randomly divided into four groups, including the control group (Group R), which received 20 ml ropivacaine 0.375% for TPVB, and the intervention groups: Group D (0.375% ropivacaine with 1 µg/kg dexmedetomidine in a total of 20 ml for TPVB), group E (0.375% ropivacaine with 0.1 mg/kg dexamethasone in a total of 20 ml for TPVB), and group S (0.375% ropivacaine with 0.5ug/ml sufentanil in a total of 20 ml for TPVB). …”

Data of research. by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Sample characterization (n = 30). by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Flowchart of sample eligibility. by Natália de Souza Duarte (18264611)

“…The root mean square of a 5-second contraction period, peak root mean square values, area values, % maximal voluntary contraction (root mean square normalized by peak signal), and median frequency were collected. …”

Expression patterns of <i>NAC</i>, <i>ASR5</i> and <i>STAR1</i> genes in rice from different development stages. by Hugo Fernando Escobar-Sepúlveda (4509883)

PEA performed for different durations of antigen/antibody binding, for three concentrations of rPCT. by Frederic Bedin (3402254)

“…<p>The time of incubation between the rPCT and the PEA probes was progressively decreased from 1h (reference test, ref.) down to 5 minutes. …”

Increased hydrophilic plasma bile acids are correlated with protection from adiposity in skin-specific stearoyl-CoA desaturase-1 deficient mice by Sabrina N. Dumas (5474456)

“…Bile acid signaling through the bile acid-specific receptor TGR5 is known to be protective against obesity and metabolic disease; a phenotype that is similar to SKO mice. …”

Table5_RAB39B as a Chemosensitivity-Related Biomarker for Diffuse Large B-Cell Lymphoma.XLSX by Cong Xu (203537)

“…DLBCL cohort analysis found that RAB39B expression was related to 14 m6A modifier genes, including YTHDC1, YTHDC2, YTHDF1, YTHDF2, YTHDF3, RBMX, ZC3H13, METTL14, METTL3, RBM15, RBM15B, VIRMA, FTO, and ALKBH5. …”

Patients’ demographics and clinical parameters. by Zi-Rong Chen (9227618)

“…</p><p>Methods</p><p>This was a prospective cohort study involving children aged 5–15 years with myopia who were treated with 0.125% atropine for myopia control. …”